athenahealth, Inc. (NASDAQ:ATHN)‘s stock had its “outperform” rating reissued by equities researchers at Evercore ISI in a research report issued on Saturday. They presently have a $163.00 price target on the health services provider’s stock, up from their previous price target of $155.00. Evercore ISI’s price objective would suggest a potential upside of 4.53% from the stock’s previous close.

A number of other equities analysts have also issued reports on ATHN. Jefferies Group LLC reiterated a “sell” rating and issued a $95.00 price target on shares of athenahealth in a report on Friday, March 24th. Piper Jaffray Companies reiterated an “overweight” rating and issued a $160.00 price target on shares of athenahealth in a report on Tuesday, April 4th. Oppenheimer Holdings, Inc. reiterated an “outperform” rating and issued a $142.00 price target on shares of athenahealth in a report on Wednesday, April 19th. Cantor Fitzgerald reiterated a “buy” rating and issued a $118.00 price target (down from $135.00) on shares of athenahealth in a report on Thursday, April 27th. Finally, Barclays PLC set a $88.00 price target on athenahealth and gave the company an “underweight” rating in a report on Monday, May 1st. One research analyst has rated the stock with a sell rating, fourteen have issued a hold rating and twelve have given a buy rating to the stock. athenahealth currently has a consensus rating of “Hold” and an average target price of $146.18.

athenahealth (NASDAQ ATHN) traded up 8.44% during mid-day trading on Friday, reaching $155.93. 2,286,356 shares of the company were exchanged. The stock has a 50-day moving average of $141.51 and a 200 day moving average of $122.62. The firm has a market capitalization of $6.21 billion, a P/E ratio of 306.95 and a beta of 1.79. athenahealth has a 1-year low of $90.11 and a 1-year high of $158.66.

athenahealth (NASDAQ:ATHN) last released its quarterly earnings results on Thursday, July 20th. The health services provider reported $0.51 EPS for the quarter, topping the consensus estimate of $0.39 by $0.12. The firm had revenue of $301.10 million for the quarter, compared to analyst estimates of $298.68 million. athenahealth had a return on equity of 7.11% and a net margin of 2.80%. athenahealth’s revenue for the quarter was up 15.0% on a year-over-year basis. During the same period in the previous year, the company posted $0.34 EPS. Equities research analysts forecast that athenahealth will post $1.86 earnings per share for the current year.

TRADEMARK VIOLATION NOTICE: This story was first reported by American Banking News and is the property of of American Banking News. If you are accessing this story on another publication, it was illegally copied and reposted in violation of U.S. & international trademark and copyright laws. The original version of this story can be viewed at https://www.americanbankingnews.com/2017/07/22/evercore-isi-reaffirms-outperform-rating-for-athenahealth-inc-athn.html.

In other news, SVP Jonathan D. Porter sold 300 shares of the company’s stock in a transaction on Monday, May 15th. The stock was sold at an average price of $109.48, for a total transaction of $32,844.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Brandon H. Hull sold 800 shares of the company’s stock in a transaction on Monday, July 3rd. The shares were sold at an average price of $140.81, for a total value of $112,648.00. The disclosure for this sale can be found here. In the last 90 days, insiders sold 26,105 shares of company stock valued at $3,394,859. Insiders own 3.20% of the company’s stock.

A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. Russell Investments Group Ltd. acquired a new position in athenahealth during the fourth quarter valued at $118,000. Comerica Bank acquired a new position in athenahealth during the fourth quarter valued at $299,000. GSA Capital Partners LLP acquired a new position in athenahealth during the fourth quarter valued at $307,000. Norges Bank acquired a new position in athenahealth during the fourth quarter valued at $20,750,000. Finally, Quadrature Capital Ltd acquired a new position in athenahealth during the fourth quarter valued at $5,759,000.

About athenahealth

athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.

Analyst Recommendations for athenahealth (NASDAQ:ATHN)

Receive News & Ratings for athenahealth Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth Inc. and related companies with MarketBeat.com's FREE daily email newsletter.